1. Home
  2. METC vs CRVS Comparison

METC vs CRVS Comparison

Compare METC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

N/A

Current Price

$15.21

Market Cap

1.8B

Sector

Energy

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$16.10

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
METC
CRVS
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
METC
CRVS
Price
$15.21
$16.10
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$33.94
$28.00
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.05
N/A
Revenue Next Year
$13.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.30
$2.54
52 Week High
$57.80
$26.95

Technical Indicators

Market Signals
Indicator
METC
CRVS
Relative Strength Index (RSI) 43.74 43.72
Support Level $14.41 $6.65
Resistance Level $19.00 $18.73
Average True Range (ATR) 1.29 0.92
MACD 0.09 -0.32
Stochastic Oscillator 29.96 20.60

Price Performance

Historical Comparison
METC
CRVS

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: